Wednesday, July 6, 2022
Market-Reporter
  • Home
  • Markets
    • U.S. Markets
    • Canada
    • Europe & Middle East
    • Emerging Markets
    • Asia
    • Latin America
  • Investing
    • Stocks
    • IPOs
    • Mutual Funds
    • ETFs
    • Bonds
    • Commodities
    • Currencies
    • Cryptocurrencies
  • Economy & Politics
    • Personal Finance
    • Spending & Saving
    • Retirement
    • Real Estate
No Result
View All Result
  • Home
  • Markets
    • U.S. Markets
    • Canada
    • Europe & Middle East
    • Emerging Markets
    • Asia
    • Latin America
  • Investing
    • Stocks
    • IPOs
    • Mutual Funds
    • ETFs
    • Bonds
    • Commodities
    • Currencies
    • Cryptocurrencies
  • Economy & Politics
    • Personal Finance
    • Spending & Saving
    • Retirement
    • Real Estate
No Result
View All Result
Market-Reporter
No Result
View All Result
Home IPOs

Krishna Institute of Medical Sciences IPO: Here’s all you need to know

MtR by MtR
June 16, 2021
in IPOs
0
Krishna Institute of Medical Sciences IPO: Here’s all you need to know




The three-day initial public offer (IPO) of Hyderabad-based Krishna Institute of Medical Sciences (KIMS) will open for subscription on Wednesday. Most of the brokerages recommend investors subscribe to the issue for a long-term considering healthy industry growth prospects and the company’s strong track record.

Related articles

Annapurna Swadisht Ipo In August | Kolkata News

July 6, 2022

Nano Labs Plans IPO of 1.77M ADSs

July 5, 2022


According to a Crisil report, the Indian healthcare industry is expected to log a CAGR of 17-18 per cent and Rs 7.1 trillion by FY24. Besides, in FY20, 68 per cent of hospital treatments, in terms of the treatment value, were carried out in private hospitals, and the number is expected to reach 72 per cent in FY24, the report said.





“Renewed impetus on Pradhan Mantri Jan Arogya Yojana, changing demographics, increasing health awareness, medical tourism, health insurance coverage and rising income levels would be the key drivers of growth for the healthcare industry,” Religare Broking said.


About the issue


The IPO comprises a fresh issue of Rs 200 crore and an offer for sale (OFS) of up to 23.56 million shares, amounting to Rs 1,943.70 crore, by its existing promoters and shareholders. The price band for the issue is in the range of Rs.815 – 825 and the bid lot is 18 shares and multiples thereof. The proceeds from the fresh issue will be used to repay debt of the company and its subsidiaries.


Business overview


KIMS is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of the number of patients treated and treatments offered. It operates nine multi-specialty hospitals under the ‘KIMS Hospitals’ brand, with an aggregate bed capacity of 3,064, including over 2,500 operational beds as of March 31, 2021.


The company has a flagship hospital at Secunderabad, which, according to Crisil, is one of the largest private hospitals in India at a single location with a capacity of 1,000 beds. At the end of FY21, its nine hospitals had recorded average revenue per operating bed of Rs 20,609, and bed occupancy rate of 78 per cent.


Over the period FY18-21, the company’s revenues grew at a 3-year CAGR of 20.4 per cent to Rs 1,329.2 crore while profit after tax (PAT) grew at 105.2 per cent to Rs 205.5 crore and earnings before interest, tax, depreciation, and ammortisation (Ebitda) at 114 per cent to Rs 370.9 crore.


KIMS experienced a CAGR of -3.96 per cent for their outpatient volume from 2019 to 2021 mainly due to Covid-19 related restrictions, although it was offset by 2.31 per cent growth of inpatient volume, which resulted in growth of total income, the company said.


Strengths & risks


Religare Broking believes that the high-quality healthcare and the company’s encouraging financial performance make KIMS well-positioned to consolidate India’s large, unorganized and yet rapidly growing and underserved affordable healthcare market. Besides, KIMS has diversified revenue streams with no single specialty accounting for more than 25 per cent of its total income in the last three years.


Meanwhile, analysts at GEPL Capital highlights KIMS’ clinical excellence and affordable healthcare (around 20-30 per cent lower prices than peers) as the key factors behind their leadership in Andhra Pradesh and Telangana. Moreover, their disciplined, low-leverage approach to acquisitions has enabled them to maintain their affordable pricing model as they have grown in both Tier 1 and Tier 2-3 markets, the brokerage said.


Going forward, KIMS intends to strengthen its existing hospitals and specialties and also strategically grow its presence in adjacent markets (Karnataka, Odisha, Tamil Nadu and even central India).


Meanwhile, according to analysts, recruitment and retaining of medical talent will remain a key challenge for KIMS. Besides, the fact that its revenue is highly reliant on hospitals in Telangana, adverse price regulations by government, delay in business normalcy, and risks associated with greenfield expansion are the other key areas of concerns, they noted.


Brokerage recommendations


Ventura expects KIMS to expand its network bed capacity to 3,800 by FY24 through a mix of brownfield and greenfield expansions while incurring a capex of around Rs 815.8 crore. As a result, the brokerage expects overall revenues to grow at a CAGR of 15.8 per cent to Rs 2,067.1 crore, PAT at 15.2 per cent to Rs 314.4 crore and Ebitda at 12.9 per cent to Rs 534.3 crore over the forecast period. It also sees KIMS becoming net debt free in FY22, owing to the company’s strong internal accruals.


“We value the stock at Rs 1,275 (17x FY24 EV/EBITDA). This represents a potential upside of 55 per cent from the IPO price of Rs. 825 per share (upper band) over the next 24 months. We recommend a SUBSCRIBE for long term investing,” it said.


“The chain’s well – calibrated capex and ability to provide specialty healthcare services at an affordable price along with a strong brand recall in the southern market augurs well. The chain’s ability to drive judicious capex into the adjacent states and Central India will drive growth in the medium term. We recommend a SUBSCRIBE rating to the issue,” GEPL Capital said.


ICICI Securities, too, recommends ‘SUBSCRIBE’ for listing gains, owing to the company’s current performance. “However, due to steep competition,expanding in others geographies may depress its financials, going ahead,” it said.








BROKERAGE

RECOMMENDATION

ICICI Securities

Subscribe

Ventura

Subscribe

GEPL Capital

Subscribe





Source link

Related Posts

Annapurna Swadisht Ipo In August | Kolkata News

by MtR
July 6, 2022
0

Kolkata: City-based Annapurna Swadisht, maker of packaged snacks, food and beverages, is planning to tap capital market with an initial...

Nano Labs Plans IPO of 1.77M ADSs

by MtR
July 5, 2022
0

By Stephen Nakrosis Nano Labs Ltd., a fabless integrated circuit design company in China, said it planned to offer 1.77...

EU set to overhaul listing rules as competition for tech IPOs intensifies

by MtR
July 5, 2022
0

Tuesday 05 July 2022 9:00 am The EU is eyeing changes to its listing rules to boost deeptech IPOs The...

Northvolt raises US$1.1bn in ‘cautious capital market’ as IPO looms

by MtR
July 5, 2022
0

Inside one of Northvolt’s laboratories. Image: Northvolt. Northvolt has raised US$1.1 billion in new capital ahead of a potential IPO...

EU set to ease IPO rules to lure $65.6 billion in deep-tech funding

by MtR
July 5, 2022
0

BRUSSELS (BLOOMBERG) - The European Union wants to increase the number of deep-tech start-ups in Europe by attracting €45 billion...

Load More
  • Trending
  • Comments
  • Latest

Bank of England tells ministers to intervene on digital currency ‘programming’

June 21, 2021

Tips for checking smoke alarms during daylight saving time

March 12, 2022

GLOBAL MARKETS-U.S. stocks follow Europe up; Treasury yields rise, dollar firm

July 9, 2021
Fed tapering and emerging markets

Fed tapering and emerging markets

June 7, 2021
African currencies week ahead: Zambia's kwacha seen on back foot, Kenyan shilling up – Business Recorder

African currencies week ahead: Zambia's kwacha seen on back foot, Kenyan shilling up – Business Recorder

0
Maxum Foods releases Global Dairy Commodity Update for June

Maxum Foods releases Global Dairy Commodity Update for June

0
Letter: Perpetual bonds can help states fight hunger

Letter: Perpetual bonds can help states fight hunger

0
United Kingdom ETFs Are Riding the Re-Opening Momentum

United Kingdom ETFs Are Riding the Re-Opening Momentum

0

Analysis: Scalded by Russia, investment funds tread carefully in China

July 6, 2022

Sensex rises 250 points, Nifty above 15,850; Asian Paints gains 3% – Economic Times

July 6, 2022

A Marxist “Hurricane” Threatens the Western Hemisphere

July 6, 2022

MARKET LIVE: Sensex, Nifty flat; metal stocks slump in pre-open

July 6, 2022

Recent News

Analysis: Scalded by Russia, investment funds tread carefully in China

July 6, 2022

Sensex rises 250 points, Nifty above 15,850; Asian Paints gains 3% – Economic Times

July 6, 2022

A Marxist “Hurricane” Threatens the Western Hemisphere

July 6, 2022

Categories

  • Asia
  • Bonds
  • Canada
  • Commodities
  • Cryptocurrencies
  • Currencies
  • Emerging Markets
  • ETFs
  • Europe & Middle East
  • IPOs
  • Latin America
  • Mutual Funds
  • Personal Finance
  • Real Estate
  • Retirement
  • Spending & Saving
  • Stocks
  • U.S. Markets
  • Privacy & Policy
  • About Us
  • Contact Us
  • Advertise with us

© 2021 Copyright Market-Reporter

No Result
View All Result
  • Home
  • Markets
    • U.S. Markets
    • Canada
    • Europe & Middle East
    • Emerging Markets
    • Asia
    • Latin America
  • Investing
    • Stocks
    • IPOs
    • Mutual Funds
    • ETFs
    • Bonds
    • Commodities
    • Currencies
    • Cryptocurrencies
  • Economy & Politics
    • Personal Finance
    • Spending & Saving
    • Retirement
    • Real Estate

© 2021 Copyright Market-Reporter